Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

NCT07431281 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2130

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer

Interventions

DRUG: Sonesitatug vedotin
DRUG: Rilvegostomig
DRUG: Nivolumab
DRUG: Capecitabine
DRUG: 5-Fluorouracil
DRUG: Oxaliplatin
DRUG: Zolbetuximab
DRUG: Leucovorin

Sponsor

AstraZeneca